In NSCLC, Single-cell RNA sequencing reveals T cell senescence correlates with poor prognosis, with a validated risk model (SLC2A1/TNS4/GGTLC1 signature, AUC > 0.8) predicting immunotherapy resistance. The gene discussed is SLC2A1; the disease is non-small cell lung carcinoma.